INNOCAN PHARMA CORPO

INNO
Delayed Quote. Delayed  - 09/24 03:59:56 pm
1CAD +1.01%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Other Pharmaceuticals
Innocan Pharma Corporation is an Israel-based pharmaceutical company active in the medical cannabis industry. It operates through three distinct operating segments: Research, Development, Marketing, Distribution and sales of InnoCan-branded over the counter (OTC) pharmaceutical products; Research and Development of Non-pharmaceutical products for third parties and Research and Development of hydrogels containing liposomes intended for licensing or sale to third party pharmaceutical corporations for manufacturing, distribution and sales. The Company is developing an OTC topical treatments product line and new platform to facilitate the targeted controlled administration of cannabinoids via injection.
Sales per Business
20192020
Cannabidiol-integrated Pharmaceuticals--0.01100%
CAD in Million
Sales per region
20192020
Israel--0.01100%
CAD in Million
Managers
Name Title
Iris Or Gabi Bincovich Chief Executive Officer & Director
Nelson Halpern Chief Financial Officer
Ron Abraham Mayron Executive Chairman
Nir Avram Chief Technology Officer
William C. MacDonald Independent Director
Yoram Nathan Drucker Director & Vice President-Business Development
Ralph C. L. Bossino Director
Joshua Aaron Lintern Director
Eyal Flom Secretary & Director
Peter David Bloch Director
Shareholders
Name Equities %
Solsken Ltd. 44,706,986 20.3%
Yoram Druker 12,201,000 5.53%
Ron Abraham Mayron 5,160,000 2.34%
Iris Or Gabi Bincovich 2,859,750 1.30%
Eyal Flom 1,837,500 0.83%
Daryl S. Fridhandler 750,001 0.34%
Nelson Halpern 500,000 0.23%
Nir Avram 0 -
Ralph C. L. Bossino 0 -
Peter David Bloch 0 -
Company contact information
InnoCan Pharma Corp.
10 Hamenofim Street
Herzliya, Tel Aviv 4672561

Web : http://www.innocanpharma.com
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
INNOCAN PHARMA CORPORATION198.51%184
JOHNSON & JOHNSON4.44%432 675
ROCHE HOLDING AG10.16%321 605
PFIZER, INC.20.05%246 358
NOVO NORDISK A/S50.45%231 485
ELI LILLY AND COMPANY37.22%210 037
ABBVIE INC.-0.07%189 211
ASTRAZENECA PLC20.77%187 304
MERCK & CO., INC.-10.01%186 334
NOVARTIS AG-8.00%186 020
BRISTOL-MYERS SQUIBB COMPANY-2.90%133 838
AMGEN INC.-7.09%121 299
SANOFI4.22%120 553
GLAXOSMITHKLINE PLC3.43%94 962
CHUGAI PHARMACEUTICAL CO., LTD.-21.79%63 921
ALLERGAN PLC0.97%63 659
TAKEDA PHARMACEUTICAL COMPANY LIMITED0.43%53 563
BAYER AG-3.45%53 487
DAIICHI SANKYO COMPANY, LIMITED-12.98%53 247
JIANGSU HENGRUI MEDICINE CO., LTD.-46.38%49 081
ASTELLAS PHARMA INC.19.35%31 844
Brand Portfolio
» More brands of InnoCan Pharma Corporation